Pharmacoeconomic effectiveness of transcranial electrical stimulation of the brain endorphynergic structures (tes-therapy) in a complex treatment of patients with type ii diabetes
Rationalization of diabetic patients treatment expenses is provided by application of the new effective medical technologies. The pharmacoeconomic analysis made using the "cost-effectiveness" method shows that application of TES therapy in a complex treatment of patients with type II diabetes has significantly cut down treatment expenses and decreased the volume of medication therapy prescribed to this group of patients.